A decision-ready blueprint
A partner-facing solution designed around the commercial realities of academic technology transfer offices and research centers.
Scientific, commercial, and digital architecture, with specialist expertise assembled where the engagement requires it.
Academic medical and translational centres need controlled environments for sharing selected research, IP, and opportunity material with prospective partners and licensees. The portal must respect institutional ownership, external-sharing approvals, and the distinct roles of researchers and technology-transfer professionals.
Lonrú Consulting designs partner portals around that workflow, giving institutions a practical route from internal opportunity assessment to governed external engagement.
We define approved research, IP, translational, partner, and institutional sources, with access and publication boundaries.
Configured systems can structure approved evidence and prepare opportunity material or review views within those controls.
Lonrú provides principal-led workflow and review governance with research, technology-transfer, and institutional approval assigned explicitly.
The approved portal provides a partner-ready opportunity workspace, controlled data room, or portfolio interface.
Share approved opportunity material with the right prospective partner under defined permissions and access controls.
Make evidence, IP context, dependencies, and approval needs visible before external engagement.
Give technology-transfer and leadership teams a usable view of selected opportunities and next actions.
Keep research, IP, publication, and partner-sharing responsibilities clear throughout the workflow.
The portal does not publish confidential research or replace the decisions held by researchers and technology-transfer teams.
We define what can be shared, who approves it, and how access is governed before an external workspace is introduced.
Relevant experience
Under 8 weeks
Architected and deployed a custom, secure Advanced Therapy Partner Portal for a specialized clinical-stage provider in under 8 weeks, moving legacy spreadsheet-based partner tracking into an automated, role-governed deal-flow engine.
Preclinical to IND
Created interactive Preclinical-to-IND decision-tree frameworks and risk-mitigation reports to help advanced-therapy enabling-technology companies align product capabilities with FDA IND validation requirements and reduce preclinical translation delays.
Architecture in context
Diagram summary: Research, IP, opportunity, partner, and institutional review inputs are brought together through ActiveArchitecture™ to support controlled external engagement.
Practical questions
Next step
Bring the decision, workflow, or delivery constraint that needs a clearer operating path.
Request a focused briefing